Session

IBD (Posters)

A MACHINE LEARNING APPROACH IDENTIFIES SPECIFIC MICROBIOTA SIGNATURE ASSOCIATED TO VARIOUS DEGREE OF ULCERATIVE COLITIS

Sonia Facchin, Brigida Barberio, Ilaria Patuzzi, Davide Massimi, Giorgio Valle, Eleonora Sattin, Elena Bertazzo, Barbara Simionati, Edoardo Vincenzo Savarino

A MACHINE LEARNING APPROACH IDENTIFIES SPECIFIC MICROBIOTA SIGNATURE ASSOCIATED TO VARIOUS DEGREE OF ULCERATIVE COLITIS

Brigida Barberio

ABDOMINAL AORTIC CALCIFICATION AS A MARKER OF CHRONIC INFLAMMATION-MEDIATED ATHEROSCLEROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

AIKATERINI MANTAKA, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis Koutroubakis

ABDOMINAL AORTIC CALCIFICATION AS A MARKER OF CHRONIC INFLAMMATION-MEDIATED ATHEROSCLEROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

AIKATERINI MANTAKA

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH IMPROVEMENTS IN CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MIRIKIZUMAB

Marla C. Dubinsky

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH IMPROVEMENTS IN CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MIRIKIZUMAB

Marla C. Dubinsky, Remo Panaccione, James D Lewis, Bruce E. Sands, Toshifumi Hibi, Scott D. Lee, April Naegeli, Mingyang Shan, Linden Green, Nathan Morris, Vipin Arora, Alison Potts Bleakman, Ruth Belin, Simon Travis

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED INFLAMMATORY BOWEL DISEASE RELATED QUALITY OF LIFE IN A PHASE 2 TRIAL OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky, Scott D. Lee, Remo Panaccione, Maria T. Abreu, Severine Vermeire, Trevor Lissoos, Nathan Morris, Vipin Arora, Mingyang Shan, April Naegeli, Bruce E. Sands

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED INFLAMMATORY BOWEL DISEASE RELATED QUALITY OF LIFE IN A PHASE 2 TRIAL OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky

ACUTE SEVERE ULCERATIVE COLITIS: IS THE NEW SCORE PROPOSED BY ACG BETTER TO PREDICT TREATMENT OUTCOMES?

Ana Luísa Santos

ACUTE SEVERE ULCERATIVE COLITIS: IS THE NEW SCORE PROPOSED BY ACG BETTER TO PREDICT TREATMENT OUTCOMES?

Ana Luísa Santos, Armando Peixoto, Isabel Garrido, Renato Medas, Ana Patrícia Andrade, Susana Lopes, Guilherme Macedo

ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH CLINICAL, BIOLOGICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN´S DISEASE

Marta Cuadros Martínez, Cristina Suárez Ferrer, Joaquin Poza Cordon, Eduardo Martín-Arranz, Maria Sanchez-Azofra, Jose Luis Rueda García, Laura García Ramirez, Patricia Mayor Delgado, Maria Angeles Ruiz-Ramirez, María Dolores Martín-Arranz

ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH CLINICAL, BIOLOGICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN_S DISEASE

Marta Cuadros Martínez

AGE RELATED PREVALENCE OF SEXUAL AND ERECTYLE DYSFUNCTION AND LOW QUALITY OF LIVE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Viktor Domislovic, Marko Brinar, Silvija Cavka Cukovic, Ana Barišić, Martin Novosel, Zeljko Krznaric

AGE RELATED PREVALENCE OF SEXUAL AND ERECTYLE DYSFUNCTION AND LOW QUALITY OF LIVE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Viktor Domislovic

ALFA-1 ANTITRYPSIN AS A REGULATING MARKER OF INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITIS

Anna Kagramanova, Oleg Knyazev, Asfold Parfenov

AN INDIRECT COMPARISON BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN CROHN 'S DISEASE: WHICH SECOND-LINE IS BETTER?

Anita Busacca, laura guida, Lucio Carrozza, Vincenza Calvaruso, Maria Cappello

AN INDIRECT COMPARISON BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN CROHN 'S DISEASE: WHICH SECOND-LINE IS BETTER?

Lucio Carrozza

AN UPDATE ON THE ANALYSIS OF NON-MELANOMA SKIN CANCER IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAMME AS OF MAY 2019

Walter Reinisch

AN UPDATE ON THE ANALYSIS OF NON-MELANOMA SKIN CANCER IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAMME AS OF MAY 2019

Bruce E. Sands, Walter Reinisch, Julian Panés, Paulo Gustavo Kotze, Donna T Judd, Rajiv Mundayat, Nervin Lawendy

ANTI-DRUG ANTIBODIES DETECTED IN THE PRESENCE OF ADEQUATE INFLIXIMAB DRUG LEVELS IN IBD PATIENTS IN CLINICAL REMISSION HAVE LIMITED CLINICAL SIGNIFICANCE

Jayne Doherty, Rachel Varley, Martin Healy, Cara Dunne, Finbar MacCarthy, Susan Mckiernan, Karen Hartery, David Kevans

ANTI-DRUG ANTIBODIES DETECTED IN THE PRESENCE OF ADEQUATE INFLIXIMAB DRUG LEVELS IN IBD PATIENTS IN CLINICAL REMISSION HAVE LIMITED CLINICAL SIGNIFICANCE

Jayne Doherty

ANTI-TNF SERUM CONCENTRATIONS ARE ASSOCIATED WITH ENDOSCOPIC REMISSION IN CROHN´S DISEASE

Marta Cuadros Martínez, Cristina Suárez Ferrer, Joaquin Poza Cordon, Eduardo Martín-Arranz, Maria Sanchez-Azofra, Jose Luis Rueda García, Laura García Ramirez, Patricia Mayor Delgado, Maria Angeles Ruiz-Ramirez, María Dolores Martín-Arranz

ANTI-TNF SERUM CONCENTRATIONS ARE ASSOCIATED WITH ENDOSCOPIC REMISSION IN CROHN_S DISEASE

Marta Cuadros Martínez

ANTI-USTEKINUMAB ANTIBODIES USING A DRUG TOLERANT ASSAY IS THE ONLY PREDICTIVE FACTOR OF CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENT UNDER USTEKINUMAB

Xavier Roblin

ANTI-USTEKINUMAB ANTIBODIES USING A DRUG TOLERANT ASSAY IS THE ONLY PREDICTIVE FACTOR OF CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENT UNDER USTEKINUMAB

Narjous CHAWKI, Mohammad CHAWKI, Pierre Cixous, Pauline Veyrard, Anne Berger, Jean Marc Phelip, Stéphane Paul, Xavier Roblin

ANXIETY, DEPRESSION AND ALEXITHYMIC TRAITS IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: CORRELATIONS WITH CLINICAL SYMPTOMS AND INFLAMMATION INDICES

Eleni Vinni, Katerina Karaivazoglou, Georgios Theocharis, Maria Kalogeropoulou, Georgia Konstantopoulou, Evanthia Tourkochristou, Paraskeui Tselekouni, Efthimia Lampropoulou, Konstantinos Thomopoulos, Konstantinos Assimakopoulos, Philippos Gourzis, Christos Triantos

ANXIETY, DEPRESSION AND ALEXITHYMIC TRAITS IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: CORRELATIONS WITH CLINICAL SYMPTOMS AND INFLAMMATION INDICES

Konstantinos Thomopoulos

ASSESSMENT OF COMORBIDITY AND PHYSICAL CAPACITY AS MARKERS FOR SAFETY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Vera Asscher

ASSESSMENT OF COMORBIDITY AND PHYSICAL CAPACITY AS MARKERS FOR SAFETY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Annemijn Maan, Vera Asscher, Femke Tijdeman, Nanda Provoost, Andrea van der Meulen-de Jong, Floor van Deudekom, Simon Mooijaart, Jeroen Maljaars

ASSESSMENT OF THE NUTRITIONAL STATUS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO DISEASE ACTIVITY

Laura María Palomino Pérez, Marta Velasco Rodríguez-Belvís, Elvira Cañedo Villaroya, Gloria Domínguez Ortega, Maria Isabel Montesinos Sánchez, Almudena Muñoz Sánchez, Paula Sánchez Llorente, Rosa Ana Muñoz Codoceo

ASSESSMENT OF THE NUTRITIONAL STATUS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO DISEASE ACTIVITY

Laura María Palomino Pérez

ASSESSMENT OF VEDOLIZUMAB DISEASE-DRUG-DRUG INTERACTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Richard A. Lirio

ASSESSMENT OF VEDOLIZUMAB DISEASE-DRUG-DRUG INTERACTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Wan Sun, Richard A. Lirio, Jennifer Schneider, Jiri Aubrecht, Harisha Kadali, Mike Baratta, Ajit Suri, Tiffany Lin, Raghavan Vasudevan, Maria Rosario

ASSOCIATION BETWEEN DURATION OF LATEST FLARE BEFORE INDUCTION TREATMENT WITH TOFACITINIB AND EFFICACY OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS

Alessandro Armuzzi

ASSOCIATION BETWEEN DURATION OF LATEST FLARE BEFORE INDUCTION TREATMENT WITH TOFACITINIB AND EFFICACY OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS

Geert D’Haens, Alessandro Armuzzi, Chinyu Su, Xiang Guo, Irene Modesto, Rajiv Mundayat, David P. Hudesman, Michael Chiorean

AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS

Simon Reider

AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS

Maria Effenberger, Simon Reider, Silvio Waschina, Christina Brunowski, Barbara Enrich, Timon Adolph, Robert Koch, Alexander R. Moschen, Philip Rosenstiel, Konrad Aden, Herbert Tilg

BI 695501 DEMONSTRATES SIMILAR EFFICACY AND COMPARABLE SAFETY TO ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH ACTIVE CROHN'S DISEASE: FINAL ANALYSIS OF THE PHASE III VOLTAIRE-CD STUDY

Stefan Schreiber

BI 695501 DEMONSTRATES SIMILAR EFFICACY AND COMPARABLE SAFETY TO ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH ACTIVE CROHN'S DISEASE: FINAL ANALYSIS OF THE PHASE III VOLTAIRE-CD STUDY

Stephen B Hanauer, Stefan Schreiber, Sigrid Balser, Ekkehard Brockstedt, Dorothy McCabe, Viktoria Moschetti, Bernd Liedert

BIO-NAIVE CROHN'S DISEASE PATIENTS WITH LONG-STANDING DISEASE BENEFIT FROM USTEKINUMAB TREATMENT: REAL WORLD EXPERIENCE

Vedran Tomasic

BIO-NAIVE CROHN'S DISEASE PATIENTS WITH LONG-STANDING DISEASE BENEFIT FROM USTEKINUMAB TREATMENT: REAL WORLD EXPERIENCE

Vedran Tomasic, David Drobne, Vladimir Borzan, Alen Bišćanin, Jurij Hanzel, Vlasta Orsic Fric, Petra Ćaćić, Borut Stabuc, Doris Ogresta, Dominik Kralj, Zdravko Dorosulic, Davor Hrabar

BIOMARKERS OF ELASTIN DEGRADATION DIFFERENTIATE BETWEEN CLINICALLY INACTIVE AND ACTIVE DISEASE IN UC PATIENTS

Martin Pehrsson, Viktor Domislovic, Morten Asser Karsdal, Marko Brinar, Ana Barišić, Zeljko Krznaric, Tina Manon Jensen, Joachim Høg Mortensen

BIOMARKERS OF ELASTIN DEGRADATION DIFFERENTIATE BETWEEN CLINICALLY INACTIVE AND ACTIVE DISEASE IN UC PATIENTS

Martin Pehrsson

BIOMARKERS OF ELASTIN DEGRADATION IS ASSOCIATED WITH CLINICAL AND BIOCHEMICALLY ACTIVE DISEASE IN CROHN'S DISEASE

Martin Pehrsson, Viktor Domislovic, Morten Asser Karsdal, Marko Brinar, Ana Barišić, Zeljko Krznaric, Tina Manon-Jensen, Joachim Høg Mortensen

BIOMARKERS OF ELASTIN DEGRADATION IS ASSOCIATED WITH CLINICAL AND BIOCHEMICALLY ACTIVE DISEASE IN CROHN'S DISEASE

Martin Pehrsson

BIOMARKERS OF EXTRACELLULAR MATRIX REMODELLING ARE ASSOCIATED WITH INTESTINAL FIBROSIS ASSESSED BY MAGNETIC RESONANCE ENTEROGRAPHY AND ACCUMULATED INTESTINAL DAMAGE (LÉMANN INDEX) - THE IBSEN STUDY

Joachim Høg Mortensen

BIOMARKERS OF EXTRACELLULAR MATRIX REMODELLING ARE ASSOCIATED WITH INTESTINAL FIBROSIS ASSESSED BY MAGNETIC RESONANCE ENTEROGRAPHY AND ACCUMULATED INTESTINAL DAMAGE (LÉMANN INDEX) - THE IBSEN STUDY

Joachim Høg Mortensen, Aida Kapic Lunder, Tina Manon-Jensen, Morten Asser Karsdal, Mette Juul Nielsen, Diana Julie Leeming, Johannes Roksund Hov, Anne Negård, Jørgen Jahnsen, Bjørn A Moum, Mette Vesterhus, Marte Lie Hoivik, Vendel A. Kristensen

BIOPSIES FROM ULCER EDGE YIELD HIGHER HISTOLOGICAL ACTIVITY SCORES THAN BIOPSIES NEXT TO ULCER IN ACTIVE ULCERATIVE COLITIS

Gregor Novak, Nejc Sever, Jurij Hanzel, Matic Koželj, Tina Kurent, Natasa Smrekar, Borut Stabuc, David Drobne, Nina Zidar

BIOPSIES FROM ULCER EDGE YIELD HIGHER HISTOLOGICAL ACTIVITY SCORES THAN BIOPSIES NEXT TO ULCER IN ACTIVE ULCERATIVE COLITIS

Gregor Novak

BODY COMPOSITION ANALYSIS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE

Aelita Kamalova

Item 1 - 50 / 569
1
2 3 4 5 6 7
...
11 12